Annual ROE
-29.11%
-78.13%-159.38%
31 December 2023
Summary:
Enliven Therapeutics annual return on equity is currently -29.11%, with the most recent change of -78.13% (-159.38%) on 31 December 2023. During the last 3 years, it has fallen by -122.52% (-131.16%). ELVN annual ROE is now -131.16% below its all-time high of 93.41%, reached on 01 December 2020.ELVN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-29.46%
-0.15%-0.51%
30 September 2024
Summary:
Enliven Therapeutics quarterly return on equity is currently -29.46%, with the most recent change of -0.15% (-0.51%) on 30 September 2024. Over the past year, it has increased by +3.25% (+9.94%). ELVN quarterly ROE is now -144.79% below its all-time high of 65.78%, reached on 30 September 2022.ELVN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELVN ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -159.4% | +9.9% |
| 3 y3 years | -131.2% | - |
| 5 y5 years | - | - |
ELVN ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -131.2% | at low | -144.8% | +67.1% |
| 5 y | 5 years | -131.2% | at low | -144.8% | +67.1% |
| alltime | all time | -131.2% | at low | -144.8% | +67.1% |
Enliven Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -29.46%(+0.5%) |
| June 2024 | - | -29.31%(+1.7%) |
| Mar 2024 | - | -28.83%(+8.5%) |
| Dec 2023 | -29.11%(-159.4%) | -26.56%(-18.8%) |
| Sept 2023 | - | -32.71%(-32.5%) |
| June 2023 | - | -48.46%(-45.9%) |
| Mar 2023 | - | -89.53%(-272.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | 49.02%(-15.0%) | 51.98%(-21.0%) |
| Sept 2022 | - | 65.78%(+8.7%) |
| June 2022 | - | 60.51%(+52.1%) |
| Mar 2022 | - | 39.78%(+103.3%) |
| Dec 2021 | 57.69%(-38.2%) | - |
| Dec 2021 | - | 19.57% |
| Dec 2020 | 93.41% | - |
FAQ
- What is Enliven Therapeutics annual return on equity?
- What is the all time high annual ROE for Enliven Therapeutics?
- What is Enliven Therapeutics annual ROE year-on-year change?
- What is Enliven Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Enliven Therapeutics?
- What is Enliven Therapeutics quarterly ROE year-on-year change?
What is Enliven Therapeutics annual return on equity?
The current annual ROE of ELVN is -29.11%
What is the all time high annual ROE for Enliven Therapeutics?
Enliven Therapeutics all-time high annual return on equity is 93.41%
What is Enliven Therapeutics annual ROE year-on-year change?
Over the past year, ELVN annual return on equity has changed by -78.13% (-159.38%)
What is Enliven Therapeutics quarterly return on equity?
The current quarterly ROE of ELVN is -29.46%
What is the all time high quarterly ROE for Enliven Therapeutics?
Enliven Therapeutics all-time high quarterly return on equity is 65.78%
What is Enliven Therapeutics quarterly ROE year-on-year change?
Over the past year, ELVN quarterly return on equity has changed by +3.25% (+9.94%)